CompanyGraph
At a glance
- Depends onUpstream position: supplies 6 industries, depends on 2
- PositionProfit margin is -5.6%, lower than 95% of its Tools & Accessories peers (median 6.4%)
- FinancialsLow earnings quality
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
5.28BCNY783.68M · vs all stocks (USD)
Revenue (TTM)
512.67MCNY76.03M · vs all stocks (USD)
Profit Margin
-5.63%vs Tools & Accessories peers
Beta
0.2690xvs all stocks
52-Week Change
-46.41%vs all stocks
Market Capitalization
5.28BCNY783.68M · vs all stocks (USD)
Enterprise Value
5.22BCNY773.52M · vs all stocks (USD)
Forward P/E
72.29xvs Tools & Accessories peers
Price to Sales (TTM)
10.14xvs Tools & Accessories peers
Price to Book (MRQ)
5.52xvs Tools & Accessories peers
Enterprise to Revenue
10.17xvs Tools & Accessories peers
Enterprise to EBITDA
147.78xvs Tools & Accessories peers
Gross Margin
11.27%vs Tools & Accessories peers
Profit Margin
-5.63%vs Tools & Accessories peers
Operating Margin
4.52%vs Tools & Accessories peers
Return on Assets (TTM)
-1.17%vs Tools & Accessories peers
Return on Equity (TTM)
-3.00%vs Tools & Accessories peers
Revenue (TTM)
512.67MCNY76.03M · vs all stocks (USD)
Revenue per Share (TTM)
4.46CNYUpdated Aug 19, 2026Quarterly Revenue Growth
9.20%vs Tools & Accessories peers
Gross Profit (TTM)
28.07MCNY4.16M · vs all stocks (USD)
EBITDA (TTM)
50.87MCNY7.54M · vs all stocks (USD)
Net Income (TTM)
-28.84MCNY-4.28M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-91.10%vs Tools & Accessories peers
Operating Cash Flow (TTM)
28.45MCNY4.22M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
-132.61MCNY-19.67M · vs all stocks (USD)
Payout Ratio
335.00%vs Tools & Accessories peers
Revenue
501.98MCNYFY2025 · Dec 31, 2025Cost of Goods Sold
455.68MCNYFY2025 · Dec 31, 2025Gross Profit
46.30MCNYFY2025 · Dec 31, 2025Operating Income
-12.76MCNY-1.89M · vs all stocks (USD)
Pre-tax Income
-33.24MCNYFY2025 · Dec 31, 2025Income Tax Expense
-7.07MCNYFY2025 · Dec 31, 2025Net Income
-26.16MCNYFY2025 · Dec 31, 2025EBIT
-28.95MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
50.87MCNYFY2025 · Dec 31, 2025Research & Development
20.80MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
18.06MCNYFY2025 · Dec 31, 2025Other Operating Expenses
4.35MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
3.01MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
4.29MCNYFY2025 · Dec 31, 2025EPS (Basic)
-0.2200CNYFY2025 · Dec 31, 2025EPS (Diluted)
-0.2200CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
118.92MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
118.92MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-26.16MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
-151.02MCNYFY2025 · Dec 31, 2025Free Cash Flow
-364.68MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
138.73MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-26.16MCNYFY2025 · Dec 31, 2025Other Non-cash Items
6.82MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-76.16MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-55.51MCNYFY2025 · Dec 31, 2025Capital Expenditures
-213.67MCNYFY2025 · Dec 31, 2025Purchase of Investments
-121.10MCNYFY2025 · Dec 31, 2025Sale of Investments
121.37MCNYFY2025 · Dec 31, 2025Other Investing Activity
8.38MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-205.02MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
339.11MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-108.63MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-12.34MCNYFY2025 · Dec 31, 2025Other Financing Charges
-2.10MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
216.03MCNYFY2025 · Dec 31, 2025Shares Outstanding
120.10MSharesUpdated Aug 19, 2026Float Shares
62.11MSharesUpdated Aug 19, 2026% Held by Insiders
48.79%vs all stocks
% Held by Institutions
10.37%vs all stocks
Total Cash (MRQ)
182.82MCNY27.11M · vs all stocks (USD)
Total Cash per Share (MRQ)
1.52CNYUpdated Aug 19, 2026Total Debt (MRQ)
294.46MCNY43.67M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.3124xvs Tools & Accessories peers
Current Ratio (MRQ)
1.12xvs Tools & Accessories peers
Book Value per Share (MRQ)
7.85CNYUpdated Aug 19, 2026Total Assets
1.60BCNY237.57M · vs all stocks (USD)
Total Current Assets
643.37MCNYFY2025 · Dec 31, 2025Total Liabilities
659.15MCNYFY2025 · Dec 31, 2025Total Non-current Assets
958.59MCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
112.45MCNYFY2025 · Dec 31, 2025Total Current Liabilities
546.70MCNYFY2025 · Dec 31, 2025Cash
138.69MCNYFY2025 · Dec 31, 2025Cash Equivalents
55.23MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
193.92MCNYFY2025 · Dec 31, 2025Accounts Receivable
190.93MCNYFY2025 · Dec 31, 2025Inventory
177.55MCNYFY2025 · Dec 31, 2025Accounts Payable
296.45MCNYFY2025 · Dec 31, 2025Short-term Debt
217.14MCNYFY2025 · Dec 31, 2025Other Current Liabilities
13.83MCNYFY2025 · Dec 31, 2025Long-term Debt
78.68MCNYFY2025 · Dec 31, 2025Common Stock (Book)
120.10MCNYFY2025 · Dec 31, 2025Retained Earnings
128.92MCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
942.81MCNY139.82M · vs all stocks (USD)
52-Week Low
35.91CNYUpdated Aug 19, 202652-Week High
85.50CNYUpdated Aug 19, 202652-Week Change
-46.41%vs all stocks
Beta
0.2690xvs all stocks
50-Day MA
42.32CNYUpdated Aug 19, 2026200-Day MA
53.95CNYUpdated Aug 19, 2026Avg 10-Day Volume
2.21MSharesUpdated Aug 19, 2026Avg 30-Day Volume
2.76MSharesUpdated Aug 19, 2026Diluted EPS (TTM)
-0.2400CNYUpdated Aug 19, 20261 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsWhere is this company structurally exposed?
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Profit margin is -5.6%, lower than 95% of its Tools & Accessories peers (median 6.4%)Significant
Profit margin: -0.06Industry median: 0.06Industry P5: -0.03Peers compared: 39.00
Current ratio is 1.12×, lower than 95% of its Tools & Accessories peers (median 2.88×)Significant
Current ratio: 1.12Industry median: 2.88Industry P5: 1.13Peers compared: 39.00
Price-to-book is 5.52×, higher than 95% of its Tools & Accessories peers (median 2.35×)Significant
Price-to-book: 5.52Industry median: 2.35Industry P95: 5.42Peers compared: 39.00
Financial Health
Low earnings qualitySignificant
Earnings Quality Score: -2.22
Altman Z-Score 5.25: safe zoneNotable
Altman Z-Score: 5.25
Supply Chain
Upstream position: supplies 6 industries, depends on 2Notable
Outgoing: 6.00Incoming: 2.00
Companies that share the same coordination system — how they create, deliver, or capture value.
Ji'an Mankun Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Chongqing Sulian Plastic Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Shandong Rike Chemical Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Shanghai Zhongchen Electronic Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Fulongma Group Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Daoming Optics & Chemical Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Yieh Phui Enterprise Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowSenseMaking
Hunan Sund Technological Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Shandong Jincheng Pharmaceutical Group Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Beijing Unistrong Science & Technology Co. Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Companies that share active interpretations — structural patterns currently present in both stocks.
Abclon Inc.
1 interpretationUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
Wanbangde Pharmaceutical Co., Ltd.
1 interpretationUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
Hyundai ADM Bio Inc.
1 interpretationUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated